Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Immediate-Release Oxycodone Capsules Study in Cancer Pain
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2018-05-21
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 242
- Registration Number
- NCT01675622
Comparison of the Efficacy of Oral Oxycodone and Oral Codeine in the Treatment of Postcraniotomy Pain
- First Posted Date
- 2012-08-24
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- Tan Tock Seng Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT01672112
- Locations
- 🇸🇬
Tan Tock Seng Hospital, Singapore, Singapore
OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Target Recruit Count
- 61
- Registration Number
- NCT01643772
- Locations
- 🇨🇳
Affiliated Hospital to Academy of Military Medical Science of China People's Liberation Army, Beijing, China
A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- GL Pharm Tech Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT01568450
- Locations
- 🇰🇷
AJOU University Hospital, Suwon, Gyeonggido, Korea, Republic of
Pharmacokinetics Study of ALO-02 and OxyContin
- Conditions
- Interventions
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2012-06-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 13
- Registration Number
- NCT01557257
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 21
- Registration Number
- NCT01552863
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 18
- Registration Number
- NCT01552850
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Oxycodone Versus Intravenous Morphine for Postoperative Analgesia After Hip Surgery
- Conditions
- Interventions
- First Posted Date
- 2012-02-22
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Target Recruit Count
- 246
- Registration Number
- NCT01536301
- Locations
- 🇫🇷
CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes Cedex 09, Gard, France
🇫🇷APHP - Groupe Hospitalier Pitié-Salpetrière, Paris, France
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2012-02-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 35
- Registration Number
- NCT01530542
- Locations
- 🇺🇸
Pfizer Investigational Site, San Antonio, Texas, United States
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
- Conditions
- Interventions
- First Posted Date
- 2012-01-02
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 81
- Registration Number
- NCT01502644
- Locations
- 🇺🇸
Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.